Health ❯ Pharmaceuticals ❯ Drug Approval Process

FDA Regulations

New Drug Application Clinical Trials Psychedelic Drug Classification Applied Therapeutics New Drug Applications Psychedelic Drugs

Corcept Investors Face April 21 Deadline to Seek Lead Role in Securities Case Over Relacorilant

Plaintiffs say Corcept misled the market about FDA concerns with relacorilant's evidence.

Cytokinetics Faces Wave of Investor Lawsuits as Lead Plaintiff Deadline Nears

Cytokinetics Investors Urged to Act as Lead‑Plaintiff Deadline Nears in REMS‑Related Securities Suit

Investor Firms Urge Cytokinetics Shareholders to Seek Lead Role in FDA-Disclosure Suit Before Nov. 17